Company Filing History:
Years Active: 2022-2024
Title: Innovations by Inventor Mario Gloeck
Introduction
Mario Gloeck is a notable inventor based in Geretsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the detection of flavivirus-specific antibodies. With a total of 3 patents to his name, Gloeck's work has implications for public health and disease prevention.
Latest Patents
Gloeck's latest patents include a method for detecting flavivirus-specific antibodies utilizing flaviviral NS1 polypeptides comprising the wing domain. This innovation relates to a polypeptide suitable for detecting antibodies against flavivirus in isolated biological samples. The polypeptide features a specific amino acid sequence from the flavivirus NS1 wing domain, ensuring that no sequences from the NS1 β-ladder domain are present. The flavivirus types targeted by this invention include Zika virus, West-Nile virus, Dengue virus types 1-4, tick-borne encephalitis virus, yellow fever virus, and Japanese encephalitis virus. Additionally, Gloeck has developed soluble and immunoreactive flaviviral NS1 polypeptides that serve similar purposes in antibody detection.
Career Highlights
Mario Gloeck is currently employed at Roche Diagnostics Operations, Inc., where he continues to innovate in the field of diagnostics. His work is crucial in developing methods that enhance the accuracy and efficiency of flavivirus detection.
Collaborations
Gloeck collaborates with esteemed colleagues such as Elke Faatz and Peter Muench, contributing to a dynamic research environment that fosters innovation.
Conclusion
Mario Gloeck's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical applications in improving public health.